Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple negative breast cancer (TNBC)

被引：0
|
作者：
Krivorotko, P. [1 ]
Zhiltsova, E. [1 ]
Gigolaeva, L. [1 ]
Emelyanov, A. [1 ]
Pesotsky, R. [1 ]
Ereschenko, S. [1 ]
Levsghenko, V. [1 ]
Nikolaev, K. [1 ]
Komayachov, A. [1 ]
Ivanova, O. [1 ]
Tabagua, T. [1 ]
Zernov, K. [1 ]
Ivanov, V. [1 ]
Aseeva, Z. [1 ]
Bessonov, A. [1 ]
Semiglazov, V. [1 ]
机构：
[1] Natl Med Res Ctr Oncol NN Petrov, St Petersburg, Russia
来源：
BREAST | 2021年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P085
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Biomarker identification of residual triple negative breast cancer (TNBC) after standard neoadjuvant chemotherapy (NCT)
    Sohn, Joohyuk
    Liu, Shuyling
    Chen, Huiqin
    Meng, Xiaolong
    Kim-Anh Do
    Mills, Gordon B.
    Hortobagyi, Gabriel N.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    [J]. CANCER RESEARCH, 2012, 72
  • [3] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    [J]. ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [4] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
  • [5] Response to Neoadjuvant Chemotherapy of Triple Negative Breast Cancer
    Tokudome, N.
    Ito, Y.
    Takahashi, S.
    Sugihara, T.
    Hosonaga, M.
    Iwasaki, R.
    Hattori, M.
    Fukuda, T.
    Mitsuhashi, K.
    Kobayashi, K.
    Taira, S.
    Saito, Y.
    Fukada, I
    Ueki, N.
    Tsutsumi, C.
    Miyagi, Y.
    Iwase, T.
    Osako, T.
    Horii, R.
    Akiyama, F.
    Hatake, K.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 571S - 572S
  • [6] Neoadjuvant chemotherapy (NCT) in 466 patients for operable breast cancer: Predictive factors for pathological response
    Abrial, C.
    Durando, X.
    Thivat, E.
    Planchat, E.
    Raoelfils, I.
    Mouret-Reynier, M.
    Gimbergues, P.
    Van Praagh-Doreau, I.
    Chollet, P. J.
    Penault-Llorca, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] The Role of CD73 in Predicting the Pathological Response to Neoadjuvant Treatment in Triple Negative Breast Cancer (TNBC)
    Cerbelli, Bruna
    Botticelli, Andrea
    Pisano, Annalinda
    Pignataro, Maria Gemma
    Naso, Giuseppe
    Monti, Massimo
    Costarelli, Leopoldo
    Magri, Valentina
    Mauri, Maria
    Campagna, Domenico
    Nuti, Marianna
    Fortunato, Lucio
    Della Rocca, Carlo
    Marchetti, Paolo
    D'Amati, Giulia
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [8] The Role of CD73 in Predicting the Pathological Response to Neoadjuvant Treatment in Triple Negative Breast Cancer (TNBC)
    Cerbelli, Bruna
    Botticelli, Andrea
    Pisano, Annalinda
    Pignataro, Maria Gemma
    Naso, Giuseppe
    Monti, Massimo
    Costarelli, Leopoldo
    Magri, Valentina
    Mauri, Maria
    Campagna, Domenico
    Nuti, Marianna
    Fortunato, Lucio
    Della Rocca, Carlo
    Marchetti, Paolo
    D'Amati, Giulia
    [J]. MODERN PATHOLOGY, 2019, 32
  • [9] Bevacizumab in Neoadjuvant Chemotherapy Increases the Pathological Complete Response Rate in Patients With Triple-Negative Breast Cancer
    Barton, Mary Kay
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (03) : 155 - 156
  • [10] A predictor of pathological complete response to neoadjuvant chemotherapy in triple -negative breast cancer patients with the DNA repair genes
    Huang, Liang
    Lang, Guan-Tian
    Liu, Qi
    Shi, Jin-Xiu
    Shao, Zhi-Ming
    Cao, A-Yong
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (04)
12345